Article
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.
Neurobiology of aging - 1 Dec 2015
Ryan Natalie S, Biessels Geert-Jan, Kim Lois, Nicholas Jennifer M, Barber Philip A, Walsh Phoebe, Gami Priya, Morris Huw R, Bastos-Leite António J, Schott Jonathan M, Beck Jon, Mead Simon, Chavez-Gutierrez Lucia, de Strooper Bart, Rossor Martin N, Revesz Tamas, Lashley Tammaryn, Fox Nick C
Abstract excerpt
Familial Alzheimer's disease (FAD) treatment trials raise interest in the variable occurrence of cerebral amyloid angiopathy (CAA); an emerging important factor in amyloid-modifying therapy. Previous pathological studies reported particularly severe CAA with postcodon 200 PSEN1 mutations and amyloid beta coding domain APP mutations. As CAA may manifest as white matter hyperintensities (WMH) on magnetic resonance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
